Stabilized hyaluronan preparations and related methods
Details for Australian Patent Application No. 2005244059 (hide)
International Classifications
Event Publications
5 June 2008 Section 223 Application Received
S.k. Pharmaceuticals, Inc. An application to extend the time from 07 Dec 2006 to 07 May 2008 in which to enter the National Phase has been filed . Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000
24 July 2008 Section 223 Application Allowed
S.k. Pharmaceuticals, Inc. The time in which to enter the National Phase has been extended to 07 May 2008. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 Extensions of Time, Section 223
7 August 2008 PCT application entered the National Phase
PCT publication WO2005/110439 Priority application(s): WO2005/110439
8 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005244061-Prevention of arterial restenosis with active vitamin D compounds
2005244058-Humanized FcgammaRIIB specific antibodies and methods of use thereof
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser